Wesfarmers Limited (WFAFF)
Juste valeurFondamental
59
Prix
$75.85
Capitalisation boursière
$83.67B
Partie 1 · Ce que vaut l'entreprise
Vue d'ensemble
Wesfarmers is an Australian conglomerate that owns a group of separately run retail and industrial businesses rather than making one product itself. Its best-known chains are Bunnings (hardware and home improvement), Kmart and Target (discount department stores) and Officeworks (office and stationery retail), alongside a health and pharmacy retail arm and a chemicals, energy and fertiliser manufacturing business, WesCEF. Each business keeps its own brand, stores and management, competing separately in its own market.
Comment l'entreprise gagne de l'argent
Revenue is largely ordinary retail sales — customers paying at the checkout in thousands of Bunnings, Kmart, Target and Officeworks stores and online across Australia and New Zealand — plus industrial sales of chemicals, explosives and fertiliser to mining and farming customers. Bunnings and Kmart Group are by far the largest contributors, each generating tens of billions of Australian dollars a year; Officeworks and WesCEF are considerably smaller. Profit depends mainly on how well each division executes in its own market, not a single group-wide driver.
Avantage concurrentiel
Marque · ÉtroitBunnings, by far the group's largest earner, is Australia's dominant home-improvement retailer, with a scale of stores and supplier relationships that a new entrant would take years to match, and a brand many Australian households default to without comparison shopping. That advantage is real for Bunnings but does not automatically extend to Wesfarmers' other, less dominant retail chains.
Ce qui stimule la demande
Modérément cycliqueThe group mixes defensive and discretionary demand: home-improvement and pharmacy spending tend to hold up reasonably well in a downturn, while discount department store sales at Kmart and Target and office-supplies sales at Officeworks are more sensitive to household budgets. WesCEF's chemicals and fertiliser business adds exposure to commodity prices and agricultural cycles that have little to do with Australian consumer spending at all.
Les arguments en faveur
Buyers argue that spreading across several leading retail brands and an industrial chemicals business smooths out a downturn in any single one, that Bunnings' scale advantage keeps compounding profit growth, and that FY2025's double-digit profit rise across most divisions shows the model still working.
Les arguments contre
Sellers worry that a conglomerate this size is hard to grow quickly from its current base, that WesCEF's earnings already fell as commodity prices weakened, and that discretionary chains like Kmart, Target and Officeworks remain exposed to a slowdown in Australian household spending.
Written by the editors, published on 18 août 2026
Direct competitors
Who this company fights with for the same customers
No editorial profile for this company yet
No competitor list for this company yet.
Bilan & Liquidités
Chiffre d'affaires
$46.47B
12 derniers mois jusqu'au dernier trimestre publié — estimation à partir de ratios par action
Résultat net
$3.07B
12 derniers mois jusqu'au dernier trimestre publié — estimation à partir de ratios par action
Flux de trésorerie libre
$3.58B
Capitaux propres totaux
$7.86B
Passif total
$12.72B
Ratio de liquidité général
1.12
Couverture des intérêts
-
Dette/EBITDA
2.64
Bénéfice par action
Chiffre d'affaires & Résultat net
Flux de trésorerie libre
Décomposition du résultat
État historique
Marges dans le temps
La dette dans le temps
Le poids de la dette
Grille de la croissance
Croissance — Chiffre d'affaires
Estimation de la juste valeur
Juste valeur
$73.43
Prix actuel
$75.85
Marge de sécurité
-3.3%
Fourchette de juste valeur
$60.26 - $86.60
Écart entre les méthodes de valorisation utilisées, pas un intervalle de confiance calibré statistiquement.
Méthodes d'estimation
Indicateurs de valorisation
Ratio P/E
28.09
ROE
33.5%
Ratio P/B
10.96
P/FCF
23.34
Marge brute
34.3%
ROIC
14.8%
Radar de rentabilité
Création de valeur (avantage concurrentiel)
ROIC
14.8%
WACC
7.4%
ROIC − WACC
+7.4 pp
Le ROIC dépasse le coût du capital — l'entreprise crée de la valeur pour les actionnaires.
Critères d'analyse fondamentale
Réussi (13)
- Price CAGR 9.88%
- ROIC 14.8%
- Gross Margin 34.3%
- P/FCF 23.34
- Debt/Equity ratio
- Operating Margin 10.0%
- Positive Free Cash Flow
- CapEx intensity
- Current Ratio
- Debt/EBITDA
- ROE 35.9%
- Revenue Growth 5Y 8.2%
- Earnings Quality (OCF/NI) 1.49
Échoué (8)
- P/B Ratio 10.96
- Price below Graham Number
- DCF valuation (Overvalued)
- Analyst Consensus 15% Buy
- Earnings Surprise avg 1.8%
- PEG Ratio 2.35
- Net Margin Trend 6.1% vs 6.4%
- Piotroski F-Score 2/9
Indisponible (6)
- EPS data insufficient
- Dividend Payout NaN%
- Interest Coverage
- Return on Tangible Assets
- Low reliance on intangibles
- Share Dilution (missing shares data)
Score F de Piotroski
Préoccupations financières sérieuses
Qualité des bénéfices
Qualité élevée : bénéfices soutenus par la trésorerie
Dilution du capital
Rachat d'actions. Favorable aux actionnaires
Participations institutionnelles
Aucune déclaration institutionnelle pour cette entreprise.
Gouvernance
Équipe dirigeante
| Nom | Titre | Âge |
|---|---|---|
| Mr. Robert Geoffrey Scott | MD, CEO & Director | 55 |
| Mr. Anthony Natale Gianotti | Chief Financial Officer | 56 |
| Ms. Aleksandra Spaseska | CFO & Managing Director of Kmart Group | - |
| Mr. Michael Schneider | MD of Bunnings Group & MD of Bunnings New Zealand | 54 |
| Ms. Maya vanden Driesen | Group General Counsel | - |
| Rebecca Keenan | Media & Public Affairs Manager | - |
| Ms. Jennifer Bryant | Chief Human Resources Officer | - |
| Ms. Marina Joanou | Managing Director of Target | - |
| Mr. Damian McGloughlin | Managing Director of BUKI | - |
| Ms. Emily Amos | Managing Director of Health | - |
Risque d'audit
4
Risque du conseil
2
Risque de rémunération
3
Risque droits des actionnaires
1
Partie 2 · Le prix et le moment d'entrer
Cette partie ne dit pas si l'entreprise vaut la peine : elle aide à choisir quand l'acheter, une fois que les fondamentaux vous ont convaincu. À l'intérieur : analyse technique, potentiel, baisses historiques, exposition gamma.
Latest News
Recent headlines for WFAFF, sourced from Markets Gazette.